The class of drugs known as checkpoint inhibitors causes an inflammation of the heart muscles. As the use of the drugs expands, researchers are sure that more people will develop deadly heart conditions. In other pharmaceutical news: FDA approval for rare drugs; lung cancer treatments; lawsuits over antipsychotic drug side effects; and right-to-try legislation.